Payment terms sit at the intersection of three risks: your cash flow risk, the manufacturer's credit risk, and the trade-finance risk between banks. Get any of these wrong and the deal collapses—or worse, ships on time and the manufacturer vanishes before the quality dispute window closes.
Three real costs of getting payment terms wrong:
A good payment term is a risk-balancing instrument, not just a money-movement mechanism. KONGDY Health structures payment terms to give both sides appropriate skin in the game.
Most international pain patch transactions use one of these six instruments. Each balances risk, speed, and cost differently.
T/T 30/70 is the workhorse of B2B pain patch trade. Here's the typical flow:
The mechanism that protects both sides: the original BOL only releases after the 70% balance clears. This gives the buyer quality leverage (factory can't ship until quality passes) and the seller payment protection (buyer can't take delivery without paying).
For orders under $30K, T/T 30/70 is often negotiated to T/T 50/50 or even 100% upfront to simplify bank charges.
A Letter of Credit substitutes the buyer's bank for the buyer's promise. The bank guarantees payment if the seller presents documents matching the L/C terms exactly. L/C at sight means the seller gets paid immediately upon document compliance—usually within 5-7 days of shipment.
For pain patch orders, the typical L/C documents list includes:
The L/C discipline is rigid: even a one-character typo on the invoice can delay payment by weeks. That's why experienced exporters and forwarders treat L/C preparation as a separate workstream from production.
L/C at sight typically costs 0.5-1.5% of order value in bank charges, divided between buyer's issuing bank and seller's advising bank. For high-value orders ($100K+), this premium is worth the security; for small orders ($30K and under), the bank fees are prohibitive.
As a buyer, you can lower the manufacturer's risk perception—and unlock better terms—by demonstrating one or more of these five levers. Each one signals a different kind of creditworthiness.
A $50K+ first order is a much stronger signal than five $10K orders. The factory prefers predictability; volume lock gives them that. KONGDY Health typically moves $50K+ buyers from T/T 50/50 to T/T 30/70 automatically.
By the third order with a clean payment history, most pain patch manufacturers will extend O/A 30 days. KONGDY's policy: 3rd order, 60+ days of clean history → O/A 30 days available.
If your bank has issued L/Cs before and the advising bank relationship is established, the manufacturer is more comfortable with deferred payment terms. L/C at sight from a Tier-1 bank is the gold standard.
Alibaba Trade Assurance or similar escrow platforms offer the manufacturer a third-party guarantee. KONGDY accepts Trade Assurance for orders up to $50K, with simplified payment terms.
A committed annual volume of $200K+ (e.g., 4 quarterly orders of $50K each) typically unlocks the best terms: 60/40 split, O/A 30 days for repeat deliveries, and locked pricing for 12 months. KONGDY offers 60/40 to annual contract buyers with verified credit.
Three currencies dominate B2B pain patch trade:
For Latin American, African, and Southeast Asian buyers, USD is almost always preferred. For European buyers, EUR is fine if the bank can settle EUR-denominated L/Cs efficiently.
B2B pain patch trade has its share of fraud patterns. Here are five to watch for:
KONGDY Health never requests payment to a personal account, never accepts L/C amendments via email alone, and never releases original BOLs before payment clears.
Here's how a typical first-time buyer approaches KONGDY Health for better terms:
"We're a private label pharmacy brand in [country]. Our first order is 50,000 pain patches with our own artwork. We have $30K ready to commit. We expect quarterly reorder cadence at 100K units each. Can you support T/T 30/70 for the first order and O/A 30 days for the second order if the first is paid on time?"
The factory's likely response, based on KONGDY's playbook:
What you say matters, but what you've done matters more. A buyer with verifiable import licenses, FDA establishment registration, and a registered pharmacy business gets 30% better terms than a similar buyer with no documentation.
The progression from cash-on-delivery terms to open-account terms is the holy grail of B2B trade finance. Here's the typical path:
The credit insurance step is critical: the factory won't extend O/A 30 days unless the buyer can prove that a default is covered. Euler Hermes and Coface are the two main credit insurance providers for Asia-Europe trade.
KONGDY Health approves O/A 30 days for buyers who complete orders 1-6 with clean payment history and provide proof of credit insurance for order 7+.
Even with the best planning, payments occasionally go sideways. Common scenarios:
The 80/20 rule for payment disputes: 80% of payment issues are caused by miscommunication, not fraud. Pick up the phone. Confirm details in writing. Document everything.
Three structural commitments:
Our payment dispute resolution rate is <2% of orders—99%+ of payments clear without a single back-and-forth email. When disputes do occur, the average resolution time is 3 business days.
Payment terms are not just a financing decision—they're a relationship investment. The manufacturer who extends T/T 30/70 to a first-time buyer is taking a real risk. The buyer who pays on time, every time, builds capital for O/A 30 days in year two.
When evaluating pain patch suppliers, ask for their payment terms ladder: how do terms evolve with order history? Which currencies do they accept? What's their L/C processing SLA? KONGDY Health publishes its payment terms policy online—no need to email for the basics.
Plan your first order with T/T 30/70. Plan your fourth order with O/A 30 days. The path is the same; the relationship grows into it.
Ready to start? Request a KONGDY quote with payment terms tailored to your order size.
